This is a StreetInsider.com Premium Only Page

(LMNL) – FDA

Jul 21, 2022 05:28 PM Liminal BioSciences (LMNL) Announces Discontinuation of Fezagepras Development

Mar 14, 2022 08:01 AM Liminal BioSciences (LMNL) Reports No Safety Findings in Phase 1 Study of fezagepras

Jun 4, 2021 03:31 PM

May 28, 2021 04:33 PM

Dec 15, 2020 09:22 AM

Sep 21, 2020 08:17 AM

Sep 8, 2020 06:16 AM

Aug 24, 2020 08:41 AM